Trial
NCT04839549
Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Eye Associates of Central Texas
Collaborators
—
Condition
Ocular Rosacea
Intervention
Dextenza 0.4Mg Ophthalmic Insert
Why stopped
Lack of patient enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-18